Quick Answer
Vor Biopharma Inc. reported Net Income Loss of -$695.98 million for the year ending 2025.
- Vor Biopharma Inc. showed a decrease of -495.3% in Net Income Loss from 2024 to 2025.
- This data is from Vor Biopharma Inc.'s annual report (Form 10-K), filed with the SEC on March 30, 2026.
- XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 6 years of available data (2020 to 2025), Vor Biopharma Inc.'s Net Income Loss has declined by 1,506.0%.
- Historical annual values: Fiscal year 2025: -$695.98 million | Fiscal year 2024: -$116.91 million | Fiscal year 2023: -$117.86 million | Fiscal year 2022: -$92.09 million | Fiscal year 2021: -$68.90 million | Fiscal year 2020: -$43.34 million.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: